PubMed COVID-19 Clinical Care
37691 - 37700 of 50647 results found
Pharmaceutical approaches for COVID-19: An update on current therapeutic opportunities
Description
SARS-CoV-2, a newly discovered coronavirus, has been linked to the COVID-19 pandemic and is currently an important public health issue. Despite all the work done to date around the world, there is still no viable treatment for COVID-19. This study
Intravital imaging of 3 different microvascular beds in SARS-CoV-2-infected mice
Description
SARS-CoV-2 enters the respiratory tract where it infects the alveoli epithelial lining. However, patients have sequelae that extend well beyond the alveoli into the pulmonary vasculature and perhaps beyond to brain and other organs. Because of the
Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study
Description
The occurrence of neurological manifestations and complications in pregnant women compared to non-pregnant women with COVID-19 is unclear. This cross-sectional study included women aged over 18 years hospitalized with SARS-CoV-2 infection confirmed
COVID-19-associated pulmonary aspergillosis in immunocompetent patients: a virtual patient cohort study
Description
The opportunistic fungus Aspergillus fumigatus infects the lungs of immunocompromised hosts, including patients undergoing chemotherapy or organ transplantation. More recently however, immunocompetent patients with severe SARS-CoV2 have been reported
The unfolded protein response components IRE1α and XBP1 promote human coronavirus infection
Description
The cellular processes that support human coronavirus replication and contribute to the pathogenesis of severe disease remain incompletely understood. Many viruses, including coronaviruses, cause endoplasmic reticulum (ER) stress during infection
Tocilizumab Associated With Survival in Patients Hospitalized for COVID-19 Acute Respiratory Distress Syndrome and Low Urine Output
Description
CONCLUSION: In this retrospective cohort review of patients hospitalized with COVID-19 and moderate or severe ARDS, tocilizumab administration was independently associated with survival in patients with low urine output ≤ 0.7 mL/kg/h on the day of
Reemployment premium effect of furlough programs: evaluating Spain's scheme during the COVID-19 crisis
Description
This paper presents an average treatment effect analysis of Spain's furlough program during the onset of the COVID-19 pandemic. Using 2020 labour force quarterly microdata, we construct a counterfactual made of comparable nonfurloughed individuals
The challenges of screen time in children with typical development and children with developmental disorders during COVID-19 pandemic
Description
CONCLUSIONS: During the COVID-19 pandemic, children's screen exposure time increased, and outdoor activities decreased significantly. This represents a significant challenge, and we should focus our efforts on managing children's screen time and
